These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36109154)

  • 1. Treatment of CIDP.
    Fehmi J; Bellanti R; Misbah SA; Bhattacharjee A; Rinaldi S
    Pract Neurol; 2023 Feb; 23(1):46-53. PubMed ID: 36109154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic inflammatory demyelinating polyneuropathy: considerations for diagnosis, management, and population health.
    Ryan M; Ryan SJ
    Am J Manag Care; 2018 Sep; 24(17 Suppl):S371-S379. PubMed ID: 30312032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
    Bunschoten C; Jacobs BC; Van den Bergh PYK; Cornblath DR; van Doorn PA
    Lancet Neurol; 2019 Aug; 18(8):784-794. PubMed ID: 31076244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic inflammatory demyelinating polyneuropathy and pregnancy: systematic review.
    Kohle F; Kuwabara S; Lehmann HC
    J Neurol Neurosurg Psychiatry; 2021 May; 92(5):473-478. PubMed ID: 33563801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic inflammatory demyelinating polyradiculoneuropathy: from bench to bedside.
    Peltier AC; Donofrio PD
    Semin Neurol; 2012 Jul; 32(3):187-95. PubMed ID: 23117943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current concepts and controversy in chronic inflammatory demyelinating polyneuropathy.
    Saperstein DS; Barohn RJ
    Curr Neurol Neurosci Rep; 2003 Jan; 3(1):57-63. PubMed ID: 12507413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conventional and unconventional therapies in typical and atypical chronic inflammatory demyelinating polyneuropathy with different clinical course of progression.
    Hung SKY; Hiew FL; Viswanathan S; Puvanarajah S
    J Peripher Nerv Syst; 2018 Sep; 23(3):183-189. PubMed ID: 30027593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are the treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) effective and safe? - A Cochrane Overview summary with commentary.
    Oaklander AL; Gimigliano F
    NeuroRehabilitation; 2019; 44(4):609-612. PubMed ID: 31256085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic inflammatory demyelinating polyneuropathy: Diagnosis and therapeutic update].
    Franques J
    Rev Med Interne; 2019 Dec; 40(12):808-815. PubMed ID: 31677862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic inflammatory demyelinating polyradiculoneuropathy-Diagnostic pitfalls and treatment approach.
    Stino AM; Naddaf E; Dyck PJ; Dyck PJB
    Muscle Nerve; 2021 Feb; 63(2):157-169. PubMed ID: 32914902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): Current Therapies and Future Approaches.
    Svačina MKR; Lehmann HC
    Curr Pharm Des; 2022; 28(11):854-862. PubMed ID: 35339172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of patients with refractory chronic inflammatory demyelinating polyneuropathy.
    Kaplan A; Brannagan TH
    Muscle Nerve; 2017 Apr; 55(4):476-482. PubMed ID: 27463215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review.
    Bright RJ; Wilkinson J; Coventry BJ
    BMC Neurol; 2014 Feb; 14():26. PubMed ID: 24507546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic inflammatory demyelinating polyneuropathy.
    Lewis RA
    Curr Opin Neurol; 2017 Oct; 30(5):508-512. PubMed ID: 28763304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between chronic inflammatory demyelinating polyneuropathy and gastrointestinal malignancies.
    Malik A; Berry R; Fung BM; Tabibian JH
    Clin J Gastroenterol; 2021 Feb; 14(1):1-13. PubMed ID: 33146871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): mechanisms of action and clinical and genetic considerations.
    Dalakas MC; Latov N; Kuitwaard K
    Expert Rev Neurother; 2022; 22(11-12):953-962. PubMed ID: 36645654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of chronic immune-mediated neuropathies: chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy, and the Lewis-Sumner syndrome.
    Sederholm BH
    Semin Neurol; 2010 Sep; 30(4):443-56. PubMed ID: 20941678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic inflammatory demyelinating polyneuropathy.
    Mathey EK; Pollard JD
    J Neurol Sci; 2013 Oct; 333(1-2):37-42. PubMed ID: 23146613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic inflammatory demyelinating polyneuropathy.
    van Doorn PA; Ruts L
    Curr Opin Neurol; 2004 Oct; 17(5):607-13. PubMed ID: 15367865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin response in treatment-naïve chronic inflammatory demyelinating polyradiculoneuropathy.
    Kuitwaard K; Hahn AF; Vermeulen M; Venance SL; van Doorn PA
    J Neurol Neurosurg Psychiatry; 2015 Dec; 86(12):1331-6. PubMed ID: 25515502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.